Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Losartan effective in chronic renal allograft rejection

May 28, 1997

MC-1288 + ciclosporin for allograft rejection

May 26, 1997

Highlights of the 7th INWIN

May 26, 1997

North American Vaccine cleared to initiate trials of meningitis vaccine

May 22, 1997

Malononitrilamides associated with potent immunosuppressive effects in animal models

May 22, 1997

VX-497: selective IMPDH inhibitor with potent immunosuppressive properties

May 22, 1997

PNP inhibitors from Chiroscience for T-cell-mediated disorders

May 21, 1997

Wyeth-Ayerst and NanoSystems agree to develop new formulation of Rapamune

May 20, 1997

Roche and Protein Design Labs report encouraging results from Zenapax trial

May 20, 1997

Phase I/II results for promising compound from BioTransplant and MedImmune

May 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...